These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 6014007)

  • 1. [Myotonolysis by means of orphenadrine citrate. Clinical and electromyographic studies in cerebral and spinal spasticity].
    Steinbrecher W
    Arzneimittelforschung; 1966 Feb; 16(2):147-53. PubMed ID: 6014007
    [No Abstract]   [Full Text] [Related]  

  • 2. [Therapy of spastic syndromes].
    Hartmann-von Monakow K
    Bibl Psychiatr Neurol; 1969; 139():114-23. PubMed ID: 4257720
    [No Abstract]   [Full Text] [Related]  

  • 3. [Clinical and electromyographic studies on the pharmacological control of spasms].
    Zschocke S; Brune G
    Verh Dtsch Ges Inn Med; 1965; 71():662-5. PubMed ID: 5877680
    [No Abstract]   [Full Text] [Related]  

  • 4. [Results of electromyographic studies with central muscle relaxants--feasibility of objectivization and standardization].
    Ollinger H; Gruber J; Singer F
    EEG EMG Z Elektroenzephalogr Elektromyogr Verwandte Geb; 1985 Jun; 16(2):104-7. PubMed ID: 3930209
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The use of drugs in the treatment of spasticity.
    Lenman JA
    Proc R Soc Med; 1970 Sep; 63(9):935-7. PubMed ID: 5477076
    [No Abstract]   [Full Text] [Related]  

  • 6. Electromyographic investigation of spasticity and muscle spasm.
    Basmajian JV
    Physiotherapy; 1976 Oct; 62(10):319-23. PubMed ID: 790427
    [No Abstract]   [Full Text] [Related]  

  • 7. Reduction of spastic hypertonia in patients with spinal cord injury: a double-blind comparison of intravenous orphenadrine citrate and placebo.
    Casale R; Glynn CJ; Buonocore M
    Arch Phys Med Rehabil; 1995 Jul; 76(7):660-5. PubMed ID: 7605186
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Windup of flexion reflexes in chronic human spinal cord injury: a marker for neuronal plateau potentials?
    Hornby TG; Rymer WZ; Benz EN; Schmit BD
    J Neurophysiol; 2003 Jan; 89(1):416-26. PubMed ID: 12522190
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Therapeutic possibilities in spasticity. Review].
    Roşianu C
    Neurol Psihiatr Neurochir; 1971; 16(1):59-70. PubMed ID: 4253575
    [No Abstract]   [Full Text] [Related]  

  • 10. A double-blind comparison in general practice of a combination tablet containing orphenadrine citrate and paracetamol ('Norgesic') with paracetamol alone.
    McGuinness BW
    J Int Med Res; 1983; 11(1):42-5. PubMed ID: 6219903
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Therapeutic experiences with a myotinolytic agent (orphenadrine citrate) in vertebral, radicular disorders].
    Gerstenbrand F; Mamoli B; Tilscher H
    Wien Med Wochenschr; 1973 Apr; 123(16):261-4. PubMed ID: 4349687
    [No Abstract]   [Full Text] [Related]  

  • 12. [Therapeutic experiences with orphenadrine citrate Norflex].
    Mathey HG
    Med Welt; 1967 Sep; 39():2320-2. PubMed ID: 4181520
    [No Abstract]   [Full Text] [Related]  

  • 13. Reflex cervical muscle spasm: treatment by diazepam, phenobarbital or placebo.
    Basmajian JV
    Arch Phys Med Rehabil; 1983 Mar; 64(3):121-4. PubMed ID: 6338860
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effect of orphenadrine citrate by injection in skeletal muscle spasm using an electromyographic examination technique.
    Whittaker VB
    Br J Clin Pract; 1969 Mar; 23(3):115-9. PubMed ID: 5774798
    [No Abstract]   [Full Text] [Related]  

  • 15. [Contractures. Clinical and physiopathological study].
    Rondot P
    Encephale; 1968; 57(4):287-332 concl. PubMed ID: 5715040
    [No Abstract]   [Full Text] [Related]  

  • 16. [MK-130, a new drug for the treatment of muscular hypertonia. Preliminary trial in 10 patients with spasticity of spinal origin].
    Molina-Negro P; Illingworth RA
    Union Med Can; 1971 Oct; 100(10):1947-51. PubMed ID: 5142212
    [No Abstract]   [Full Text] [Related]  

  • 17. [Problems in scientific research on infantile cerebral palsy].
    Stotz S
    Munch Med Wochenschr; 1973 Apr; 115(16):704-7. PubMed ID: 4740415
    [No Abstract]   [Full Text] [Related]  

  • 18. Change of stretch reflex threshold in spasticity: effect of botulinum toxin injections.
    Stampacchia G; Bradaschia E; Rossi B
    Arch Ital Biol; 2004 May; 142(3):265-73. PubMed ID: 15260380
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Traditional pharmacological treatments for spasticity. Part II: General and regional treatments.
    Gracies JM; Nance P; Elovic E; McGuire J; Simpson DM
    Muscle Nerve Suppl; 1997; 6():S92-120. PubMed ID: 9826984
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Methodology of analgesic-muscle relaxant evaluation. Experience with orphenadrine citrate compound.
    Batterman RC
    Proc West Pharmacol Soc; 1965; 8():22. PubMed ID: 5324034
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.